These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 34299283)

  • 1. X Chromosome Inactivation in Carriers of Fabry Disease: Review and Meta-Analysis.
    Viggiano E; Politano L
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-inactivation in Fabry disease.
    Elstein D; Schachamorov E; Beeri R; Altarescu G
    Gene; 2012 Sep; 505(2):266-8. PubMed ID: 22710134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-chromosome inactivation in female patients with Fabry disease.
    Echevarria L; Benistan K; Toussaint A; Dubourg O; Hagege AA; Eladari D; Jabbour F; Beldjord C; De Mazancourt P; Germain DP
    Clin Genet; 2016 Jan; 89(1):44-54. PubMed ID: 25974833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Female Fabry disease patients and X-chromosome inactivation.
    Juchniewicz P; Kloska A; Tylki-Szymańska A; Jakóbkiewicz-Banecka J; Węgrzyn G; Moskot M; Gabig-Cimińska M; Piotrowska E
    Gene; 2018 Jan; 641():259-264. PubMed ID: 29079200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-chromosome inactivation patterns in females with Fabry disease examined by both ultra-deep RNA sequencing and methylation-dependent assay.
    Rossanti R; Nozu K; Fukunaga A; Nagano C; Horinouchi T; Yamamura T; Sakakibara N; Minamikawa S; Ishiko S; Aoto Y; Okada E; Ninchoji T; Kato N; Maruyama S; Kono K; Nishi S; Iijima K; Fujii H
    Clin Exp Nephrol; 2021 Nov; 25(11):1224-1230. PubMed ID: 34128148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of X chromosome inactivation with clinical presentation of Fabry disease in a case report.
    Rodríguez Doyágüez P; Furlano M; Ars Criach E; Arce Y; Guirado L; Torra Balcells R
    Nefrologia (Engl Ed); 2023 Dec; 43 Suppl 2():91-95. PubMed ID: 38278716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population.
    Dobrovolny R; Dvorakova L; Ledvinova J; Magage S; Bultas J; Lubanda JC; Elleder M; Karetova D; Pavlikova M; Hrebicek M
    J Mol Med (Berl); 2005 Aug; 83(8):647-54. PubMed ID: 15806320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skewed X-chromosome inactivation plays a crucial role in the onset of symptoms in carriers of Becker muscular dystrophy.
    Viggiano E; Picillo E; Ergoli M; Cirillo A; Del Gaudio S; Politano L
    J Gene Med; 2017 Apr; 19(4):. PubMed ID: 28316128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anderson-Fabry disease: a multiorgan disease.
    Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
    Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-chromosomal inactivation patterns in women with Fabry disease.
    Wagenhäuser L; Rickert V; Sommer C; Wanner C; Nordbeck P; Rost S; Üçeyler N
    Mol Genet Genomic Med; 2022 Sep; 10(9):e2029. PubMed ID: 35971858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease manifestations and X inactivation in heterozygous females with Fabry disease.
    Maier EM; Osterrieder S; Whybra C; Ries M; Gal A; Beck M; Roscher AA; Muntau AC
    Acta Paediatr Suppl; 2006 Apr; 95(451):30-8. PubMed ID: 16720462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation impact on Fabry disease.
    Di Risi T; Vinciguerra R; Cuomo M; Della Monica R; Riccio E; Cocozza S; Imbriaco M; Duro G; Pisani A; Chiariotti L
    Clin Epigenetics; 2021 Feb; 13(1):24. PubMed ID: 33531072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanisms of Skewed X-Chromosome Inactivation in Female Hemophilia Patients-Lessons from Wide Genome Analyses.
    Dardik R; Avishai E; Lalezari S; Barg AA; Levy-Mendelovich S; Budnik I; Barel O; Khavkin Y; Kenet G; Livnat T
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-Linked Emery-Dreifuss Muscular Dystrophy: Study Of X-Chromosome Inactivation and Its Relation with Clinical Phenotypes in Female Carriers.
    Viggiano E; Madej-Pilarczyk A; Carboni N; Picillo E; Ergoli M; Gaudio SD; Marchel M; Nigro G; Palladino A; Politano L
    Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31718017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pitfalls of X-chromosome inactivation testing in females with Fabry disease.
    Řeboun M; Sikora J; Magner M; Wiederlechnerová H; Černá A; Poupětová H; Štorkánova G; Mušálková D; Dostálová G; Goláň L; Linhart A; Dvořáková L
    Am J Med Genet A; 2022 Jul; 188(7):1979-1989. PubMed ID: 35338595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fabry disease. Clinical and genetic aspects. Therapeutic perspectives].
    Germain DP
    Rev Med Interne; 2000 Dec; 21(12):1086-103. PubMed ID: 11191676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligosymptomatic cornea verticillata in a heterozygote for Fabry disease: a novel mutation in the alpha-galactosidase gene.
    Kono JO; Podskarbi T; Shin Y; Lanzl I
    Cornea; 2003 Mar; 22(2):175-7. PubMed ID: 12605057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural course of Fabry disease with the p. Arg227Ter (p.R227*) mutation in Finland: Fast study.
    Pietilä-Effati P; Saarinen JT; Löyttyniemi E; Autio R; Saarenhovi M; Haanpää MK; Kantola I
    Mol Genet Genomic Med; 2019 Oct; 7(10):e00930. PubMed ID: 31411008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophy.
    Viggiano E; Ergoli M; Picillo E; Politano L
    Hum Genet; 2016 Jul; 135(7):685-98. PubMed ID: 27098336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of multiple angiomas without any angiokeratomas in a female heterozygote with Fabry disease.
    Mirceva V; Hein R; Ring J; Möhrenschlager M
    Australas J Dermatol; 2010 Feb; 51(1):36-8. PubMed ID: 20148840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.